
Global Livestock Foot and Mouth Disease (FMD) Vaccines Market Outlook and Growth Opportunities 2025
Description
Summary
According to APO Research, the global Livestock Foot and Mouth Disease (FMD) Vaccines market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Livestock Foot and Mouth Disease (FMD) Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Livestock Foot and Mouth Disease (FMD) Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Livestock Foot and Mouth Disease (FMD) Vaccines market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Livestock Foot and Mouth Disease (FMD) Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Livestock Foot and Mouth Disease (FMD) Vaccines market include Sanofi (Merial), Jinyu Group, Bayer HealthCare, VETAL, VECOL, Tecon Group, Shen Lian, MSD Animal Health and ME VAC, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Livestock Foot and Mouth Disease (FMD) Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Livestock Foot and Mouth Disease (FMD) Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Livestock Foot and Mouth Disease (FMD) Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Livestock Foot and Mouth Disease (FMD) Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Livestock Foot and Mouth Disease (FMD) Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Livestock Foot and Mouth Disease (FMD) Vaccines sales, projected growth trends, production technology, application and end-user industry.
Livestock Foot and Mouth Disease (FMD) Vaccines Segment by Company
Sanofi (Merial)
Jinyu Group
Bayer HealthCare
VETAL
VECOL
Tecon Group
Shen Lian
MSD Animal Health
ME VAC
LIMOR
Indian Immunologicals
FGBI
CEVA
Cavet Bio
CAHIC
BVI
Brilliant Bio Pharma
Boehringer Ingelheim
Biogenesis Bagó
BIGVET Biotech
Agrovet
Livestock Foot and Mouth Disease (FMD) Vaccines Segment by Type
Emergency Vaccines
Conventional Vaccines
Livestock Foot and Mouth Disease (FMD) Vaccines Segment by Application
Pig
Cattle
Sheep and Goat
Others
Livestock Foot and Mouth Disease (FMD) Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Livestock Foot and Mouth Disease (FMD) Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Livestock Foot and Mouth Disease (FMD) Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Livestock Foot and Mouth Disease (FMD) Vaccines significant trends, drivers, influence factors in global and regions.
6. To analyze Livestock Foot and Mouth Disease (FMD) Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Livestock Foot and Mouth Disease (FMD) Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Livestock Foot and Mouth Disease (FMD) Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Livestock Foot and Mouth Disease (FMD) Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Livestock Foot and Mouth Disease (FMD) Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Livestock Foot and Mouth Disease (FMD) Vaccines industry.
Chapter 3: Detailed analysis of Livestock Foot and Mouth Disease (FMD) Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Livestock Foot and Mouth Disease (FMD) Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Livestock Foot and Mouth Disease (FMD) Vaccines in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
According to APO Research, the global Livestock Foot and Mouth Disease (FMD) Vaccines market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Livestock Foot and Mouth Disease (FMD) Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Livestock Foot and Mouth Disease (FMD) Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Livestock Foot and Mouth Disease (FMD) Vaccines market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Livestock Foot and Mouth Disease (FMD) Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Livestock Foot and Mouth Disease (FMD) Vaccines market include Sanofi (Merial), Jinyu Group, Bayer HealthCare, VETAL, VECOL, Tecon Group, Shen Lian, MSD Animal Health and ME VAC, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Livestock Foot and Mouth Disease (FMD) Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Livestock Foot and Mouth Disease (FMD) Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Livestock Foot and Mouth Disease (FMD) Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Livestock Foot and Mouth Disease (FMD) Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Livestock Foot and Mouth Disease (FMD) Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Livestock Foot and Mouth Disease (FMD) Vaccines sales, projected growth trends, production technology, application and end-user industry.
Livestock Foot and Mouth Disease (FMD) Vaccines Segment by Company
Sanofi (Merial)
Jinyu Group
Bayer HealthCare
VETAL
VECOL
Tecon Group
Shen Lian
MSD Animal Health
ME VAC
LIMOR
Indian Immunologicals
FGBI
CEVA
Cavet Bio
CAHIC
BVI
Brilliant Bio Pharma
Boehringer Ingelheim
Biogenesis Bagó
BIGVET Biotech
Agrovet
Livestock Foot and Mouth Disease (FMD) Vaccines Segment by Type
Emergency Vaccines
Conventional Vaccines
Livestock Foot and Mouth Disease (FMD) Vaccines Segment by Application
Pig
Cattle
Sheep and Goat
Others
Livestock Foot and Mouth Disease (FMD) Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Livestock Foot and Mouth Disease (FMD) Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Livestock Foot and Mouth Disease (FMD) Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Livestock Foot and Mouth Disease (FMD) Vaccines significant trends, drivers, influence factors in global and regions.
6. To analyze Livestock Foot and Mouth Disease (FMD) Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Livestock Foot and Mouth Disease (FMD) Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Livestock Foot and Mouth Disease (FMD) Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Livestock Foot and Mouth Disease (FMD) Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Livestock Foot and Mouth Disease (FMD) Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Livestock Foot and Mouth Disease (FMD) Vaccines industry.
Chapter 3: Detailed analysis of Livestock Foot and Mouth Disease (FMD) Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Livestock Foot and Mouth Disease (FMD) Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Livestock Foot and Mouth Disease (FMD) Vaccines in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Table of Contents
213 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value (2020-2031)
- 1.2.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume (2020-2031)
- 1.2.3 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Average Price (2020-2031)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
- 2 Livestock Foot and Mouth Disease (FMD) Vaccines Market Dynamics
- 2.1 Livestock Foot and Mouth Disease (FMD) Vaccines Industry Trends
- 2.2 Livestock Foot and Mouth Disease (FMD) Vaccines Industry Drivers
- 2.3 Livestock Foot and Mouth Disease (FMD) Vaccines Industry Opportunities and Challenges
- 2.4 Livestock Foot and Mouth Disease (FMD) Vaccines Industry Restraints
- 3 Livestock Foot and Mouth Disease (FMD) Vaccines Market by Company
- 3.1 Global Livestock Foot and Mouth Disease (FMD) Vaccines Company Revenue Ranking in 2024
- 3.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Revenue by Company (2020-2025)
- 3.3 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume by Company (2020-2025)
- 3.4 Global Livestock Foot and Mouth Disease (FMD) Vaccines Average Price by Company (2020-2025)
- 3.5 Global Livestock Foot and Mouth Disease (FMD) Vaccines Company Ranking (2023-2025)
- 3.6 Global Livestock Foot and Mouth Disease (FMD) Vaccines Company Manufacturing Base and Headquarters
- 3.7 Global Livestock Foot and Mouth Disease (FMD) Vaccines Company Product Type and Application
- 3.8 Global Livestock Foot and Mouth Disease (FMD) Vaccines Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Livestock Foot and Mouth Disease (FMD) Vaccines Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
- 3.9.3 2024 Livestock Foot and Mouth Disease (FMD) Vaccines Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
- 4 Livestock Foot and Mouth Disease (FMD) Vaccines Market by Type
- 4.1 Livestock Foot and Mouth Disease (FMD) Vaccines Type Introduction
- 4.1.1 Emergency Vaccines
- 4.1.2 Conventional Vaccines
- 4.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume by Type
- 4.2.1 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume by Type (2020-2031)
- 4.2.3 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume Share by Type (2020-2031)
- 4.3 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Type
- 4.3.1 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (2020 VS 2024 VS 2031)
- 4.3.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (2020-2031)
- 4.3.3 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type (2020-2031)
- 5 Livestock Foot and Mouth Disease (FMD) Vaccines Market by Application
- 5.1 Livestock Foot and Mouth Disease (FMD) Vaccines Application Introduction
- 5.1.1 Pig
- 5.1.2 Cattle
- 5.1.3 Sheep and Goat
- 5.1.4 Others
- 5.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume by Application
- 5.2.1 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume by Application (2020-2031)
- 5.2.3 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume Share by Application (2020-2031)
- 5.3 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Application
- 5.3.1 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Application (2020 VS 2024 VS 2031)
- 5.3.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Application (2020-2031)
- 5.3.3 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application (2020-2031)
- 6 Livestock Foot and Mouth Disease (FMD) Vaccines Regional Sales and Value Analysis
- 6.1 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales by Region: 2020 VS 2024 VS 2031
- 6.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales by Region (2020-2031)
- 6.2.1 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales by Region: 2020-2025
- 6.2.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales by Region (2026-2031)
- 6.3 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Region: 2020 VS 2024 VS 2031
- 6.4 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Region (2020-2031)
- 6.4.1 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Region: 2020-2025
- 6.4.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Region (2026-2031)
- 6.5 Global Livestock Foot and Mouth Disease (FMD) Vaccines Market Price Analysis by Region (2020-2025)
- 6.6 North America
- 6.6.1 North America Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value (2020-2031)
- 6.6.2 North America Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Country, 2024 VS 2031
- 6.7 Europe
- 6.7.1 Europe Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value (2020-2031)
- 6.7.2 Europe Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Country, 2024 VS 2031
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value (2020-2031)
- 6.8.2 Asia-Pacific Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Country, 2024 VS 2031
- 6.9 South America
- 6.9.1 South America Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value (2020-2031)
- 6.9.2 South America Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Country, 2024 VS 2031
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value (2020-2031)
- 6.10.2 Middle East & Africa Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Country, 2024 VS 2031
- 7 Livestock Foot and Mouth Disease (FMD) Vaccines Country-level Sales and Value Analysis
- 7.1 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales by Country: 2020 VS 2024 VS 2031
- 7.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Country: 2020 VS 2024 VS 2031
- 7.3 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales by Country (2020-2031)
- 7.3.1 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales by Country (2020-2025)
- 7.3.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales by Country (2026-2031)
- 7.4 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Country (2020-2031)
- 7.4.1 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Country (2020-2025)
- 7.4.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Country (2026-2031)
- 7.5 USA
- 7.5.1 USA Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.5.2 USA Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.5.3 USA Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.6 Canada
- 7.6.1 Canada Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.6.2 Canada Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Canada Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.7 Mexico
- 7.6.1 Mexico Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.6.2 Mexico Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Mexico Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.8 Germany
- 7.8.1 Germany Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.8.2 Germany Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.8.3 Germany Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.9 France
- 7.9.1 France Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.9.2 France Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.9.3 France Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.10 U.K.
- 7.10.1 U.K. Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.10.2 U.K. Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.10.3 U.K. Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.11 Italy
- 7.11.1 Italy Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.11.2 Italy Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.11.3 Italy Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.12 Spain
- 7.12.1 Spain Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.12.2 Spain Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.12.3 Spain Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.13 Russia
- 7.13.1 Russia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.13.2 Russia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.13.3 Russia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.14 Netherlands
- 7.14.1 Netherlands Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.14.2 Netherlands Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.14.3 Netherlands Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.15.2 Nordic Countries Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.15.3 Nordic Countries Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.16 China
- 7.16.1 China Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.16.2 China Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.16.3 China Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.17 Japan
- 7.17.1 Japan Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.17.2 Japan Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.17.3 Japan Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.18 South Korea
- 7.18.1 South Korea Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.18.2 South Korea Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.18.3 South Korea Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.19 India
- 7.19.1 India Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.19.2 India Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.19.3 India Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.20 Australia
- 7.20.1 Australia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.20.2 Australia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.20.3 Australia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.21.2 Southeast Asia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.21.3 Southeast Asia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.22 Brazil
- 7.22.1 Brazil Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.22.2 Brazil Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.22.3 Brazil Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.23 Argentina
- 7.23.1 Argentina Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.23.2 Argentina Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.23.3 Argentina Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.24 Chile
- 7.24.1 Chile Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.24.2 Chile Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.24.3 Chile Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.25 Colombia
- 7.25.1 Colombia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.25.2 Colombia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.25.3 Colombia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.26 Peru
- 7.26.1 Peru Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.26.2 Peru Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.26.3 Peru Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.27.2 Saudi Arabia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.27.3 Saudi Arabia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.28 Israel
- 7.28.1 Israel Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.28.2 Israel Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.28.3 Israel Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.29 UAE
- 7.29.1 UAE Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.29.2 UAE Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.29.3 UAE Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.30 Turkey
- 7.30.1 Turkey Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.30.2 Turkey Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.30.3 Turkey Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.31 Iran
- 7.31.1 Iran Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.31.2 Iran Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.31.3 Iran Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 7.32 Egypt
- 7.32.1 Egypt Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2020-2031)
- 7.32.2 Egypt Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2024 VS 2031
- 7.32.3 Egypt Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2024 VS 2031
- 8 Company Profiles
- 8.1 Sanofi (Merial)
- 8.1.1 Sanofi (Merial) Comapny Information
- 8.1.2 Sanofi (Merial) Business Overview
- 8.1.3 Sanofi (Merial) Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.1.4 Sanofi (Merial) Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
- 8.1.5 Sanofi (Merial) Recent Developments
- 8.2 Jinyu Group
- 8.2.1 Jinyu Group Comapny Information
- 8.2.2 Jinyu Group Business Overview
- 8.2.3 Jinyu Group Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.2.4 Jinyu Group Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
- 8.2.5 Jinyu Group Recent Developments
- 8.3 Bayer HealthCare
- 8.3.1 Bayer HealthCare Comapny Information
- 8.3.2 Bayer HealthCare Business Overview
- 8.3.3 Bayer HealthCare Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.3.4 Bayer HealthCare Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
- 8.3.5 Bayer HealthCare Recent Developments
- 8.4 VETAL
- 8.4.1 VETAL Comapny Information
- 8.4.2 VETAL Business Overview
- 8.4.3 VETAL Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.4.4 VETAL Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
- 8.4.5 VETAL Recent Developments
- 8.5 VECOL
- 8.5.1 VECOL Comapny Information
- 8.5.2 VECOL Business Overview
- 8.5.3 VECOL Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.5.4 VECOL Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
- 8.5.5 VECOL Recent Developments
- 8.6 Tecon Group
- 8.6.1 Tecon Group Comapny Information
- 8.6.2 Tecon Group Business Overview
- 8.6.3 Tecon Group Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.6.4 Tecon Group Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
- 8.6.5 Tecon Group Recent Developments
- 8.7 Shen Lian
- 8.7.1 Shen Lian Comapny Information
- 8.7.2 Shen Lian Business Overview
- 8.7.3 Shen Lian Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.7.4 Shen Lian Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
- 8.7.5 Shen Lian Recent Developments
- 8.8 MSD Animal Health
- 8.8.1 MSD Animal Health Comapny Information
- 8.8.2 MSD Animal Health Business Overview
- 8.8.3 MSD Animal Health Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.8.4 MSD Animal Health Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
- 8.8.5 MSD Animal Health Recent Developments
- 8.9 ME VAC
- 8.9.1 ME VAC Comapny Information
- 8.9.2 ME VAC Business Overview
- 8.9.3 ME VAC Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.9.4 ME VAC Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
- 8.9.5 ME VAC Recent Developments
- 8.10 LIMOR
- 8.10.1 LIMOR Comapny Information
- 8.10.2 LIMOR Business Overview
- 8.10.3 LIMOR Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.10.4 LIMOR Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
- 8.10.5 LIMOR Recent Developments
- 8.11 Indian Immunologicals
- 8.11.1 Indian Immunologicals Comapny Information
- 8.11.2 Indian Immunologicals Business Overview
- 8.11.3 Indian Immunologicals Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.11.4 Indian Immunologicals Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
- 8.11.5 Indian Immunologicals Recent Developments
- 8.12 FGBI
- 8.12.1 FGBI Comapny Information
- 8.12.2 FGBI Business Overview
- 8.12.3 FGBI Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.12.4 FGBI Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
- 8.12.5 FGBI Recent Developments
- 8.13 CEVA
- 8.13.1 CEVA Comapny Information
- 8.13.2 CEVA Business Overview
- 8.13.3 CEVA Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.13.4 CEVA Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
- 8.13.5 CEVA Recent Developments
- 8.14 Cavet Bio
- 8.14.1 Cavet Bio Comapny Information
- 8.14.2 Cavet Bio Business Overview
- 8.14.3 Cavet Bio Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.14.4 Cavet Bio Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
- 8.14.5 Cavet Bio Recent Developments
- 8.15 CAHIC
- 8.15.1 CAHIC Comapny Information
- 8.15.2 CAHIC Business Overview
- 8.15.3 CAHIC Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.15.4 CAHIC Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
- 8.15.5 CAHIC Recent Developments
- 8.16 BVI
- 8.16.1 BVI Comapny Information
- 8.16.2 BVI Business Overview
- 8.16.3 BVI Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.16.4 BVI Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
- 8.16.5 BVI Recent Developments
- 8.17 Brilliant Bio Pharma
- 8.17.1 Brilliant Bio Pharma Comapny Information
- 8.17.2 Brilliant Bio Pharma Business Overview
- 8.17.3 Brilliant Bio Pharma Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.17.4 Brilliant Bio Pharma Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
- 8.17.5 Brilliant Bio Pharma Recent Developments
- 8.18 Boehringer Ingelheim
- 8.18.1 Boehringer Ingelheim Comapny Information
- 8.18.2 Boehringer Ingelheim Business Overview
- 8.18.3 Boehringer Ingelheim Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.18.4 Boehringer Ingelheim Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
- 8.18.5 Boehringer Ingelheim Recent Developments
- 8.19 Biogenesis Bagó
- 8.19.1 Biogenesis Bagó Comapny Information
- 8.19.2 Biogenesis Bagó Business Overview
- 8.19.3 Biogenesis Bagó Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.19.4 Biogenesis Bagó Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
- 8.19.5 Biogenesis Bagó Recent Developments
- 8.20 BIGVET Biotech
- 8.20.1 BIGVET Biotech Comapny Information
- 8.20.2 BIGVET Biotech Business Overview
- 8.20.3 BIGVET Biotech Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.20.4 BIGVET Biotech Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
- 8.20.5 BIGVET Biotech Recent Developments
- 8.21 Agrovet
- 8.21.1 Agrovet Comapny Information
- 8.21.2 Agrovet Business Overview
- 8.21.3 Agrovet Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2020-2025)
- 8.21.4 Agrovet Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
- 8.21.5 Agrovet Recent Developments
- 9 Value Chain and Sales Channels Analysis
- 9.1 Livestock Foot and Mouth Disease (FMD) Vaccines Value Chain Analysis
- 9.1.1 Livestock Foot and Mouth Disease (FMD) Vaccines Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Livestock Foot and Mouth Disease (FMD) Vaccines Sales Mode & Process
- 9.2 Livestock Foot and Mouth Disease (FMD) Vaccines Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Livestock Foot and Mouth Disease (FMD) Vaccines Distributors
- 9.2.3 Livestock Foot and Mouth Disease (FMD) Vaccines Customers
- 10 Concluding Insights
- 11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.